A contract research organization announced that it is expending its North American outreach with a location in Greater Toronto, Canada.
ClinChoice provides clinical research services in pharmaceutics, vaccines, medical devices, consumer products, cosmetics and nutraceuticals, according to a company press release.
The new location in Canada joins previous ClinChoice locations in the U.S., Armenia, China, India, Japan, the Philippines and the United Kingdom, according to the press release.
"The Toronto center will provide us with additional access to top-tier talent with close proximity to many of our clients," Ling Zhen, chairman and global CEO of ClinChoice, said in the release.
ClinChoice offers services in clinical operations, biostatistics, project management, regulatory affairs, pharmacovigilance, medical writing, toxicology and AI-based IT solutions and implementation, the release said. The company's mission is, "to contribute to a healthier and safer world by accelerating the development and commercialization of innovative drugs and devices," according to its website.
The organization has about 2,200 professionals dedicated to the organization across the globe, the release said.
"For over 25 years, ClinChoice has provided excellent clinical development services to many biopharmaceutical companies globally," the website states. "The resources and talents in Canada will join the more than 2200 ClinChoice employees globally and greatly enhance our commitment to delivering quality and efficient research services to facilitate the development of much needed innovative therapies and products to patients as quickly as possible."
ClinChoice offers expertise in 30-plus therapeutic areas with dedicated teams on the topics, according to its website.
"Our commitment to the highest quality standards, flexibility, and timeline fulfillment has earned us and our clients consistent results," ClinChoice says on its website. "We provide services for the full development lifecycle to a wide range of clients, large and small, including six of the top 10 pharmaceutical companies, as well as small to midsize biotechnology companies. For us, our record of quality means consistency, accuracy and reliability."